LINAC Devices Global Market Report 2024

The linac devices market has grown strongly in recent years. It will grow from $4.79 billion in 2023 to $5.24 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The expansion observed in the historical period can be attributed to factors such as advancements in treatment delivery speed, the standardization and regulation of LINAC technology, growth in radiosurgery and stereotactic radiosurgery procedures, enhanced safety features incorporated into LINAC devices, and improvements in the integration of imaging technologies.

The linac devices market is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The anticipated growth in the forecast period can be attributed to factors such as the rise in cancer incidences, the development of adaptive radiotherapy techniques, increasing demand for image-guided radiation therapy (IGRT), enhanced safety features leading to improved patient comfort, and the integration of artificial intelligence (AI) in LINAC technology. Key trends expected in the forecast period include the development of innovative software solutions, advancements in adaptive radiotherapy techniques, the integration of telemedicine, incorporation of motion management technologies, and a heightened focus on patient-centric care within the field of LINAC technology.

The anticipated increase in cancer cases is set to drive the growth of the LINAC devices market. Cancer, characterized by uncontrolled cell growth and the spread of abnormal cells within the body, is a target for treatment using Linear Accelerators (LINAC) in radiation therapy. These devices deliver high-energy X-rays externally to the cancer site to treat various forms of cancer. Notably, data from the American Cancer Society in January 2023 indicates a rise in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, marking a 3.16% growth. Consequently, the growing number of cancer cases is a significant factor propelling the LINAC devices market.

The increasing healthcare expenditure is poised to contribute to the growth of the LINAC devices market. Healthcare expenditure, representing the total financial outlay on healthcare goods and services within a specific timeframe, encompasses the costs associated with advanced oncology treatments using Linear Accelerator (LINAC) devices. For example, projections from the Canadian Institute for Health Information (CIHI) in November 2022 forecast a 0.8% increase in total health spending in Canada, from $328 billion in 2021 to $331 billion in 2022. This upward trend in healthcare expenditure is a driving force behind the LINAC devices market.

Technological advancements emerge as a prominent trend in the LINAC devices market, with major companies introducing innovative products such as the ViewRay MRIdian MRI-Guided Radiation Therapy System to maintain their market position. In March 2023, GenesisCare, a US-based provider of cancer and cardiac care, launched an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. The MRIdian system combines precision radiation therapy with state-of-the-art, high-resolution MRI guidance, potentially reducing the number of treatment sessions required. This technological innovation, exemplified by MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy, marks a significant trend in the LINAC devices market.

Major players in the LINAC devices market focus on technical innovation, such as the development of MRI-radiation therapy machines, to revolutionize cancer treatment and enhance market profitability. An MRI-radiation therapy machine integrates magnetic resonance imaging (MRI) technology with a linear accelerator (LINAC) for radiation therapy. In February 2021, Elekta, a Sweden-based precision radiation therapy solutions innovator, introduced Elekta Unity, an MRI-radiation therapy machine in Korea. This groundbreaking device combines a high-resolution 1.5 T MRI scanner with a seven-megavolt linear accelerator, providing real-time high-resolution MRI images during treatment. Elekta Unity allows for customized radiation therapy based on tumor conditions, reducing patient hospital visits, particularly for breast, thyroid, and prostate tumors. This technological advancement enhances patient care and complements existing linear accelerators for comprehensive cancer treatment.

In April 2021, Siemens Healthineers AG, a Germany-based medical device manufacturer, completed the acquisition of Varian Medical Systems Inc. for $16.4 billion. This strategic move allowed Siemens to enter the cancer care and overall healthcare sector. Varian Medical Systems, a US-based manufacturer of linear accelerators and stereotactic surgery devices, added valuable capabilities to Siemens Healthineers' portfolio in the LINAC devices market.

Major companies operating in the linac devices market report are Accuracy Inc., Elekta AB, GE Healthcare Technologies Inc., Hitachi Ltd., Huiheng Medical Inc., Koninklijke Philips N.V., Mitsubishi Heavy Industries Ltd., Top Grade Healthcare Group, Varian Medical Systems Inc., Siemens Healthineers GmbH, Shinva Medical Instrument Co. Ltd., Altair Technologies Inc., BEVATECH GmbH, CGN Dasheng Electron Accelerator Technology Company Limited, Diondo GmbH, IBA SA, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., Viewray Technologies Inc., MeVion Medical Systems Inc., Sumitomo Heavy Industries Ltd., ProNova Solutions LLC, RaySearch Laboratories AB, P-Cure Ltd., Best Theratronics Ltd., Advanced Oncotherapy PLC, RefleXion Medical Inc., Nanobiotix S A, C-RAD AB, Theragenics Corporation, Isoray Inc., Nordion Inc.

North America was the largest region in the LINAC devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global LINAC devices market report during the forecast period. The regions covered in the linac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the linac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main products of LINAC devices include high-energy, low-energy, and medium-energy devices. A high-energy linear accelerator (LINAC) operates at energies ranging from 20 to 50 million electron volts (MeV). It is used to produce high-energy X-rays or electron beams for radiation therapy, particularly for treating tumors located deep within the body. Linear accelerator and non-dedicated linear accelerator methods are employed in the treatment of various cancers such as breast cancer, colorectal cancer, head and neck cancer, lung cancer, prostate cancer, and others. These devices find application in clinics, hospitals, and research centers.

The LINAC devices market research report provides LINAC devices market statistics, including the LINAC devices industry global market size, regional shares, competitors with a LINAC devices market share, detailed LINAC devices market segments, market trends, and opportunities, and any further data you may need to thrive in the LINAC devices industry. This LINAC devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The LINAC devices market consists of sales of an electron generation component, beam transport equipment, radiotherapy equipment, imaging and monitoring accessory. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.